Related Experiment Video
Updated: Aug 10, 2025
07:30
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
10.1K
Basic research and clinical progress of sepsis-associated encephalopathy
Ying Huang1, Ruman Chen2, Lai Jiang1
1Department of Anesthesiology and Surgical Intensive Care Unit, Xin-Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
Journal of Intensive Medicine
|February 15, 2023
Summary
Sepsis-associated encephalopathy (SAE) affects many ICU patients, causing severe consciousness impairment and high mortality. While its cause is unclear, targeting mitochondrial dysfunction may offer a future treatment approach for this serious brain complication.
Area of Science:
- Neurology
- Critical Care Medicine
- Pathophysiology
Background:
- Sepsis-associated encephalopathy (SAE) is a frequent and severe complication in intensive care unit (ICU) patients.
- SAE significantly impacts consciousness and is linked to elevated mortality rates.
- Current understanding of SAE pathogenesis remains incomplete.
Purpose of the Study:
- To review current literature on SAE, covering epidemiology, clinical features, pathology, diagnosis, and management.
- To highlight the challenges in diagnosing and treating SAE.
- To explore potential therapeutic strategies for SAE.
Main Methods:
- Comprehensive literature review of studies on sepsis-associated encephalopathy.
- Analysis of existing data on SAE epidemiology and clinical manifestations.
- Evaluation of diagnostic techniques and current management strategies for SAE.
Main Results:
- SAE affects up to 70% of ICU patients, presenting with significant neurological impairment.
- Various non-invasive methods like electroencephalography aid in brain assessment.
- No definitive pharmacological treatment currently exists for SAE.
Conclusions:
- SAE is a critical neurological complication of sepsis with high morbidity and mortality.
- Further research into SAE pathogenesis is essential for developing effective treatments.
- Mitochondrial dysfunction is a potential therapeutic target for managing SAE.
